1. Home
  2. HFBL vs AEON Comparison

HFBL vs AEON Comparison

Compare HFBL & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HFBL
  • AEON
  • Stock Information
  • Founded
  • HFBL 1924
  • AEON N/A
  • Country
  • HFBL United States
  • AEON United States
  • Employees
  • HFBL N/A
  • AEON N/A
  • Industry
  • HFBL Savings Institutions
  • AEON Biotechnology: Pharmaceutical Preparations
  • Sector
  • HFBL Finance
  • AEON Health Care
  • Exchange
  • HFBL Nasdaq
  • AEON Nasdaq
  • Market Cap
  • HFBL 39.4M
  • AEON 36.4M
  • IPO Year
  • HFBL N/A
  • AEON N/A
  • Fundamental
  • Price
  • HFBL $12.29
  • AEON $0.55
  • Analyst Decision
  • HFBL
  • AEON Strong Buy
  • Analyst Count
  • HFBL 0
  • AEON 1
  • Target Price
  • HFBL N/A
  • AEON $5.00
  • AVG Volume (30 Days)
  • HFBL 2.1K
  • AEON 111.7K
  • Earning Date
  • HFBL 10-29-2024
  • AEON 11-13-2024
  • Dividend Yield
  • HFBL 4.24%
  • AEON N/A
  • EPS Growth
  • HFBL N/A
  • AEON N/A
  • EPS
  • HFBL 1.09
  • AEON N/A
  • Revenue
  • HFBL $19,727,000.00
  • AEON N/A
  • Revenue This Year
  • HFBL N/A
  • AEON N/A
  • Revenue Next Year
  • HFBL N/A
  • AEON N/A
  • P/E Ratio
  • HFBL $11.30
  • AEON N/A
  • Revenue Growth
  • HFBL N/A
  • AEON N/A
  • 52 Week Low
  • HFBL $10.60
  • AEON $0.55
  • 52 Week High
  • HFBL $15.81
  • AEON $17.17
  • Technical
  • Relative Strength Index (RSI)
  • HFBL 46.34
  • AEON 25.60
  • Support Level
  • HFBL $12.14
  • AEON $0.65
  • Resistance Level
  • HFBL $12.40
  • AEON $0.88
  • Average True Range (ATR)
  • HFBL 0.19
  • AEON 0.07
  • MACD
  • HFBL -0.01
  • AEON -0.02
  • Stochastic Oscillator
  • HFBL 31.58
  • AEON 0.27

About HFBL Home Federal Bancorp Inc. of Louisiana

Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Share on Social Networks: